Point‐of‐care laboratory halves door‐to‐therapy‐decision time in acute stroke
- 14 December 2010
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 69 (3), 581-586
- https://doi.org/10.1002/ana.22355
Abstract
Currently, stroke laboratory examinations are usually performed in the centralized hospital laboratory, but often planned thrombolysis is given before all results are available, to minimize delay. In this study, we examined the feasibility of gaining valuable time by transferring the complete stroke laboratory workup required by stroke guidelines to a point‐of‐care laboratory system, that is, placed at a stroke treatment room contiguous to the computed tomography, where the patients are admitted and where they obtain neurological, laboratory, and imaging examinations and treatment by the same dedicated team. Our results showed that reconfiguration of the entire stroke laboratory analysis to a point‐of‐care system was feasible for 200 consecutively admitted patients. This strategy reduced the door‐to‐therapy‐decision times from 84 ± 26 to 40 ± 24 min (p < 0.001). Results of most laboratory tests (except activated partial thromboplastin time and international normalized ratio) revealed close agreement with results from a standard centralized hospital laboratory. These findings may offer a new solution for the integration of laboratory workup into routine hyperacute stroke management. Ann Neurol 2011;Keywords
This publication has 17 references indexed in Scilit:
- Bringing the Hospital to the Patient: First Treatment of Stroke Patients at the Emergency SitePLOS ONE, 2010
- Point‐of‐care reversal treatment in phenprocoumon‐related intracerebral hemorrhageAnnals of Neurology, 2010
- Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral AnticoagulantsStroke, 2009
- Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008Cerebrovascular Diseases, 2008
- REPRINTCirculation, 2007
- Guidelines for the Early Management of Adults With Ischemic StrokeCirculation, 2007
- “Mobile Stroke Unit” for Hyperacute Stroke TreatmentStroke, 2003
- Tissue Plasminogen Activator for Acute Ischemic StrokeThe New England Journal of Medicine, 1995
- Viability thresholds and the penumbra of focal ischemiaAnnals of Neurology, 1994
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986